1. Cytoreductive Surgery (Debulking):
   - Complete removal of visible tumors (optimal: <1cm residual)
   - Includes: Hysterectomy + Bilateral salpingo-oophorectomy + Omentectomy
   - Success rate: 80% 5-year survival if Stage IIIc with <1cm residual

2. Platinum-Based Chemotherapy:
   - First-line: Carboplatin (AUC 5-6) + Paclitaxel (175mg/m²) q3w x6 cycles
   - Response rate: 70-80% (BRCA+ patients: 90%)
   - Maintenance: PARP inhibitors (Olaparib/Niraparib) for BRCA+ tumors

3. Hyperthermic Intraperitoneal Chemotherapy (HIPEC):
   - Heated (41-43°C) cisplatin perfusion during surgery
   - 50% recurrence reduction in Stage III trials (OVHIPEC-1)